Companies: 10,795·Total market cap: $144.5T
Vicarious Surgical Inc.

Vicarious Surgical Inc.

RBOTOTCHealthcare● Active
$0.55
+$0.01(+2.54%)
Market Cap$3558625
P/E Ratio
52W High$13.746
52W Low$0.27
Overview

Vicarious Surgical Inc. (RBOT) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

rbot · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Vicarious Surgical Inc. (RBOT) measures how much investors pay for each dollar of the company's trailing earnings. RBOT's current PE ratio of N/A is calculated by dividing its stock price of $0.55 by its TTM earnings per share of -$6.29.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-4.07
Based on 1 analyst
EPS (TTM)
-$6.29
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Vicarious Surgical Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2019 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 50.5x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Vicarious Surgical Inc.
Vicarious Surgical Inc.You
RBOT
$4MN/A-$6.29
Boundless Bio, Inc.
Boundless Bio, Inc.
BOLD
$32MN/A-$2.60
Hyperion DeFi, Inc.
Hyperion DeFi, Inc.
HYPD
$14MN/A-$9.06
Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc.
INTS
$7MN/A-$0.86
Iterum Therapeutics plc
Iterum Therapeutics plc
ITRM
$2MN/A-$1.26
Modular Medical, Inc.
Modular Medical, Inc.
MODD
$10MN/A-$15.26
Myomo, Inc.
Myomo, Inc.
MYO
$54MN/A-$0.37

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-8.45
2024-12-31
FY2024
$-10.74
2023-12-31
FY2023
$-14.70
2022-12-31
FY2022
50.45x$1.20
2021-12-31
FY2021
$-10.93
2020-12-31
FY2020
$-3.76
2019-12-31
FY2019
$-1.70

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Vicarious Surgical Inc. (RBOT) measures how much investors pay for each dollar of the company's trailing earnings. RBOT's current PE ratio of N/A is calculated by dividing its stock price of $0.55 by its TTM earnings per share of -$6.29.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.55 ÷ -$6.29 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

RBOT pe ratio · 6 questions

RBOT's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.55 and TTM EPS of -$6.29. Data sourced from Financial Modeling Prep via RBOT's SEC 10-K and 10-Q filings.

RBOT PE ratioWhat is RBOT PE ratioCurrent PE ratio of RBOTRBOT PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Vicarious Surgical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09